These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6538986)

  • 1. Sleep patterns in cats during chronic low-dose barbiturate treatment and withdrawal.
    Hinman DJ; Okamoto M
    Sleep; 1984; 7(1):69-76. PubMed ID: 6538986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physical dependence to barbital compared to pentobarbital. III. Withdrawal characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):514-25. PubMed ID: 564952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical dependence to barbital compared to pentobarbital. II. Tolerance characteristics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):507-13. PubMed ID: 564951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical and subcortical EEG patterns during moderate-intensity barbiturate withdrawal.
    Hinman DJ; Okamoto M
    Exp Neurol; 1984 Mar; 83(3):555-67. PubMed ID: 6538142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic morphine administration in cats: effects on sleep and EEG.
    De Andrés I; Caballero A
    Pharmacol Biochem Behav; 1989 Feb; 32(2):519-26. PubMed ID: 2727014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of atropine on the tolerance and the convulsions seen after withdrawal from forced barbital drinking in the rat.
    Wahlström G
    Psychopharmacology (Berl); 1978 Oct; 59(2):123-8. PubMed ID: 103112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic suppression of REM sleep by parenteral administration of the serotonin-1 agonist eltoprazine.
    Quattrochi JJ; Mamelak A; Binder DK; Williams J; Rittenhouse C; Hobson JA
    Sleep; 1992 Apr; 15(2):125-32. PubMed ID: 1579786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of tolerance to chronic barbital treatment in the cerebellar cyclic guanosine monophosphate system and its response to subsequent barbital abstinence.
    Lane SJ; Morgan WW
    J Pharmacol Exp Ther; 1985 Sep; 234(3):569-74. PubMed ID: 2993585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of REM rebound after barbiturate withdrawal.
    Feinberg I; Hibi S; Cavness C; March J
    Science; 1974 Aug; 185(4150):534-5. PubMed ID: 4366490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Counterpointing the functional role of the forebrain and of the brainstem in the control of the sleep-waking system.
    Villablanca JR
    J Sleep Res; 2004 Sep; 13(3):179-208. PubMed ID: 15339255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of propranolol on barbital dependence formation and withdrawal signs.
    Tagashira E; Hiramori T; Urano T; Nakao K; Yanaura S
    Jpn J Pharmacol; 1983 Feb; 33(1):133-43. PubMed ID: 6683767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of an alkaloid-rich extract from Mitragyna speciosa leaves and fluoxetine on sleep profiles, EEG spectral frequency and ethanol withdrawal symptoms in rats.
    Cheaha D; Keawpradub N; Sawangjaroen K; Phukpattaranont P; Kumarnsit E
    Phytomedicine; 2015 Oct; 22(11):1000-8. PubMed ID: 26407942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Physical dependence to barbital compared to pentobarbital. I. "Chronically equivalent" dosing method.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):497-506. PubMed ID: 564950
    [No Abstract]   [Full Text] [Related]  

  • 18. Cyclic AMP-induced changes in the electroencephalogram and in behavior during morphine dependence and abstinence in the rat.
    Shahid Salles KS; Colasanti BK; Craig CR
    Sleep; 1979; 1(3):247-57. PubMed ID: 228372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in sleep polygraphy after neuroleptic withdrawal: a putative supersensitive dopaminergic mechanism.
    Thaker GK; Wagman AM; Kirkpatrick B; Tamminga CA
    Biol Psychiatry; 1989 Jan; 25(1):75-86. PubMed ID: 2563233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of long-term forced oral barbital administration on endogenous acetylcholine in different regions of rat brain.
    Nordberg A; Wahlström G
    Eur J Pharmacol; 1977 Jun; 43(3):237-42. PubMed ID: 559577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.